%0 Journal Article
%A Daskalakis, Michael
%A Feller, Anita
%A Noetzli, Jasmine
%A Bonadies, Nicolas
%A Arndt, Volker
%A Baerlocher, Gabriela Maria
%A The Nicer Working Group
%T Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017.
%J Cancers
%V 13
%N 24
%@ 2072-6694
%C Basel
%I MDPI
%M DKFZ-2021-03246
%P 6269
%D 2021
%X Tyrosine kinase inhibitors (TKI) substantially improved chronic myeloid leukemia (CML) prognosis. We aimed to describe time period- and age-dependent outcomes by reporting real-world data of CML patients from Switzerland.Population-based incidence, mortality, and survival were assessed for four different study periods and age groups on the basis of aggregated data from Swiss Cantonal Cancer Registries.A total of 1552 new CML cases were reported from 1995 to 2017. The age-standardized rate (ASR) for the incidence remained stable, while the ASR for mortality decreased by 50-80
%K CML (Other)
%K incidence (Other)
%K mortality (Other)
%K relative survival (Other)
%K tyrosine kinase inhibitor (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:34944892
%R 10.3390/cancers13246269
%U https://inrepo02.dkfz.de/record/178299